Histerectomía en mujeres en edad reproductiva con diagnóstico de miomatosis uterina tratadas con acetato de leuprolide en el Hospital Teodoro Maldonado Carbo en el periodo de enero 2014 a diciembre 2016.

Abstract

Introduction: Uterine myomatosis is the most common cause of solid tumors in women's pelvis, occurring in 20-40% of women of childbearing age. Objective: To determine the prevalence of Hysterectomy in women of reproductive age with diagnosis of uterine myomatosis treated with Leuprolide Acetate at Teodoro Maldonado Carbo Hospital from January 2014 to December 2016. Material and method: To determine effectiveness Of leuprolide acetate in women of reproductive age with a diagnosis of uterine fibroids who were subsequently hysterectomized at the Hospital Teodoro Maldonado Carbo in the period from January 2014 to December 2016, information was collected on-site using the collected clinical records. Population characteristics and study findings will be presented using simple frequencies. The database will be designed in an Excel 2013 electronic sheet of Microsoft Office. Processing will be done using Excel's advanced analysis application. The causal sample was 76 women of reproductive age with diagnosis of uterine myoma treated with leuprolide acetate. RESULTS: According to the results obtained and in contrast to the literature used in the current research it is objected that the most frequent age of myoma pathologies is between 40 and 45 years of age with up to 3 times the disease in most of th e Cases. The most common myoma is intramural and submucosal which present with more repetition in type 2 size and usually a dose of treatment is needed for it to be controlled. Myomas that distort the uterine cavity (submucosal or intramural with an intracavitary component) imply a difficulty in conception and an increase in the rate of abortion. There were 49 patients of the total sample were given with a single dose of treatment, of these 49 patients were 28 hysterectomized, in the second dose were 19 hysterectomized and the third dose 4. In total 51 patients of 76 were hysterectomized representing 67 % of total sample.